BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 29, 2010
View Archived Issues
Concert Pharmaceuticals claims new inhibitors of VEGFR-1, -2 and -3
Read More
Clinical data disclosed on Locteron/ribavirin vs. PEG-Intron/ribavirin in HCV genotype 1
Read More
Synta claims new dual CRAC and IL-2 inhibitors
Read More
Actelion claims novel orexin receptor antagonists
Read More
U.S. scientists claim new fused diimidazodiazepine agents
Read More
Pfizer details discovery and activity of dual PI3K/mTOR inhibitor PF-04691502
Read More
Phase II data presented on pasireotide in Cushing's disease and acromegaly
Read More
In vivo safety and antitumor activity of ABI-013 disclosed
Read More
L-Hyd4FC shows potent in vivo activity in HBV-infected mice
Read More
MK-5172 shows potent preclinical activity against resistance-linked HCV NS3/4a protease variants
Read More
Enrollment complete in OSI's phase III trial of erlotinib in NSCLC
Read More
Vertex provides pipeline update for first quarter of 2010
Read More
Erythropoietin does not show benefit in pediatric cardiac surgery
Read More
Osiris achieves milestone for remestemcel-L development progress in Japan
Read More
Clovis and Ventana to jointly develop diagnostic test for CO-1.01 trial in pancreatic cancer
Read More
ChronTech provides update on ChronSeal and ChronVac-C trials
Read More
FDA grants orphan drug status to Atir for the reduction of transplant-related mortality
Read More
Covidien launches Exalgo extended-release tablets in U.S. for pain management
Read More
Dexlansoprazole now available under new name Dexilant in U.S.
Read More
Pharmaxis resubmits Adriol NDA to FDA for diagnosis of asthma
Read More
Phase II brostallicin/cisplatin trial in triple-negative breast cancer planned
Read More
NeuroSearch claims new dopamine and serotonin receptor modulators
Read More
AdventRx to resubmit ANX-530 NDA in fourth quarter of 2010
Read More
BioCryst reports on phase IIa trial of BCX-4208 in patients with gout
Read More
DARA and NCI collaborate to advance KRN-5500 in cancer trial
Read More
Diamyd Medical continues phase III trials of Diamyd in diabetes
Read More
